Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial.
作者信息
Christiansen C, Rodbro P, Lund M
出版信息
Br Med J. 1973 Apr 28;2(5860):208-9. doi: 10.1136/bmj.2.5860.208.
Abstract
The bone mineral mass was estimated by photon absorptiometry in 23 epileptic patients on long-term treatment with phenytoin and in 20 normal subjects before and during treatment with vitamin D or placebo.Initially, subnormal values of bone mineral mass were found in the epileptic patients. The group of epileptic patients treated with vitamin D showed a significant increase in bone mineral mass. The group of epileptic patients treated with placebo and the normal subjects treated with vitamin D or placebo showed no change in bone mineral mass.
摘要
相似文献
1
Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial.
Br Med J. 1973 Apr 28;2(5860):208-9. doi: 10.1136/bmj.2.5860.208.
2
Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial.癫痫患儿医源性骨软化症。一项对照治疗试验。
Acta Paediatr Scand. 1975 Mar;64(2):219-24. doi: 10.1111/j.1651-2227.1975.tb03825.x.
3
Latent osteomalacia in epileptic patients on anticonvulsants.服用抗惊厥药的癫痫患者中的潜在骨软化症。
Br Med J. 1972 Sep 23;3(5829):738-9. doi: 10.1136/bmj.3.5829.738.
4
Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment.
Acta Neurol Scand. 1974;50(4):527-32. doi: 10.1111/j.1600-0404.1974.tb02798.x.
5
"Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study.
Br Med J. 1974 May 4;2(5913):258-9. doi: 10.1136/bmj.2.5913.258.
6
Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial.抗惊厥药所致骨软化症的发病率及维生素D的作用：对照治疗试验
Br Med J. 1973 Dec 22;4(5894):695-701. doi: 10.1136/bmj.4.5894.695.
7
Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients.
Acta Neurol Scand. 1983 Dec;68(6):424-8. doi: 10.1111/j.1600-0404.1983.tb04854.x.
8
Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.预防慢性癫痫患者的骨质流失和椎体骨折——抗癫痫药物与骨质疏松预防试验。
Epilepsia. 2013 Nov;54(11):1997-2004. doi: 10.1111/epi.12351. Epub 2013 Sep 6.
9
The effect of vitamin D2 treatment on bone mineral after partial gastrectomy.
Scand J Gastroenterol. 1977;12(4):497-9. doi: 10.3109/00365527709181694.
10
Effects of anticonvulsant drug therapy on bone mineral density in a pediatric population.
J Pediatr Orthop. 1988 Jul-Aug;8(4):467-70. doi: 10.1097/01241398-198807000-00017.
引用本文的文献
1
Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D.比较观察性研究和随机对照试验中维生素 D 对非骨骼健康影响的证据。
Nutrients. 2022 Sep 15;14(18):3811. doi: 10.3390/nu14183811.
2
Effect of Daily Vitamin D Supplementation on Serum Vitamin D Levels in Children with Epilepsy Receiving Sodium Valproate Monotherapy: A Randomized, Controlled Trial.每日补充维生素 D 对接受丙戊酸钠单药治疗的癫痫患儿血清维生素 D 水平的影响：一项随机对照试验。
Indian J Pediatr. 2023 May;90(5):450-456. doi: 10.1007/s12098-022-04225-w. Epub 2022 Jun 28.
3
Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy.抗癫痫药物对癫痫患儿骨骼健康和生长潜力的影响。
Paediatr Drugs. 2015 Apr;17(2):141-50. doi: 10.1007/s40272-014-0115-z.
4
The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.抗惊厥药物引起慢性肝酶诱导的临床后果。
Br J Clin Pharmacol. 1974 Jun;1(3):185-7. doi: 10.1111/j.1365-2125.1974.tb00233.x.
5
Low dose phenytoin is an osteogenic agent in the rat.
Calcif Tissue Int. 1995 Jan;56(1):42-8. doi: 10.1007/BF00298743.
6
Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation.通过直接光子吸收法测量接受长期抗惊厥治疗和多种维生素补充剂的机构养老成年人的骨矿物质状况。
Calcif Tissue Int. 1980;31(2):117-21. doi: 10.1007/BF02407172.
7
Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial.抗惊厥药所致骨软化症的发病率及维生素D的作用：对照治疗试验
Br Med J. 1973 Dec 22;4(5894):695-701. doi: 10.1136/bmj.4.5894.695.
8
Anticonvulsant osteomalacia.抗惊厥药所致骨软化症
Br Med J. 1976 Dec 4;2(6048):1340-1.
9
[The frequency of adult anticonvulsant osteomalacia in relation to duration of therapy and dosage of anticonvulsants (author's transl)].
Arch Psychiatr Nervenkr (1970). 1979 Apr 12;226(4):299-310. doi: 10.1007/BF00342242.
本文引用的文献
1
Precision and accuracy of bone mineral determination by direct photon absorptiometry.
Invest Radiol. 1968 May-Jun;3(3):141-50. doi: 10.1097/00004424-196805000-00001.
2
[Bone structure changes in long-term anticonvulsant treatment].[长期抗惊厥治疗中的骨骼结构变化]
Dtsch Gesundheitsw. 1970 Aug 13;25(33):1549-51.
3
Disturbance of calcium metabolism by anticonvulsant drugs.
Br Med J. 1970 Oct 10;4(5727):73-6. doi: 10.1136/bmj.4.5727.73.
4
Osteomalacia with long-term anticonvulsant therapy in epilepsy.癫痫患者长期抗惊厥治疗导致的骨软化症。
Br Med J. 1970 Oct 10;4(5727):69-72. doi: 10.1136/bmj.4.5727.69.
5
Bone density in patients receiving long-term anticonvulsant therapy.
Acta Neurol Scand. 1971;47(5):650-1. doi: 10.1111/j.1600-0404.1971.tb07517.x.
6
Rapid determination of serum diphenylhydantoin by gas chromatography.气相色谱法快速测定血清中的苯妥英
Med Lab Technol. 1971 Oct;28(4):377-81.
7
Altered calcium metabolism in epileptic children on anticonvulsants.接受抗惊厥药物治疗的癫痫儿童的钙代谢改变。
Br Med J. 1971 Oct 23;4(5781):202-4. doi: 10.1136/bmj.4.5781.202.
8
Latent osteomalacia in epileptic patients on anticonvulsants.服用抗惊厥药的癫痫患者中的潜在骨软化症。
Br Med J. 1972 Sep 23;3(5829):738-9. doi: 10.1136/bmj.3.5829.738.
9
The mineral content in bone. Measured by means of 27.5 keV radiation from 125I.骨骼中的矿物质含量。通过来自¹²⁵I的27.5 keV辐射进行测量。
Acta Radiol Suppl. 1972;313:214-20.
10
[Osteopathies in antiepileptic long-term therapy (preliminary report)].[抗癫痫长期治疗中的骨病（初步报告）]
Monatsschr Kinderheilkd (1902). 1968 Jun;116(6):378-81.
Zotero 插件